https://eprints.whiterose.ac.uk/id/eprint/43233/
Designing phase II trials in cancer: a systematic review and guidance - White Rose Research Online
phase ii trialssystematic reviewwhite rosedesigningcancer
https://www.businesswire.com/news/home/20250205112716/en/Qlaris-Bio-Announces-Positive-Topline-Data-From-Two-Phase-II-Trials-of-QLS-111-in-Patients-With-Primary-Open-Angle-Glaucoma-and-Ocular-Hypertension
Qlaris Bio Announces Positive Topline Data From Two Phase II Trials of QLS-111 in Patients With...
Qlaris Bio, Inc., a clinical-stage biotechnology company targeting unmet needs in debilitating ophthalmic diseases, today announced positive topline results ...
phase ii trialsbioannouncespositivetopline
https://brandonbiocatalyst.com/2018/10/02/que-oncology-launches-phase-ii-trials/
QUE Oncology launches Phase II trials – Brandon BioCatalyst
phase ii trialsqueoncologylaunchesbrandon
https://www.clinicaltrialsarena.com/news/bioxodes-haemorrhagic-stroke-drug-biox-101-phase-iia/
Bioxodes’ haemorrhagic stroke hopeful to progress after Phase II success - Clinical Trials Arena
Oct 29, 2025 - If approved, Bioxodes' BIOX-101 could become the first treatment for haemorrhagic stroke outside of surgical intervention.
haemorrhagic strokephase iiclinical trialshopefulprogress